![]() |
市場調查報告書
商品編碼
2024757
疝氣修補網片市場分析:按疝氣類型、網片類型、最終用戶和地區分類(2026-2034 年)Hernia Mesh Devices Market Report by Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others), Mesh (Biologic Mesh, Synthetic Mesh), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Region 2026-2034 |
||||||
2025年,全球疝氣修補網片市場規模達21億美元。展望未來,IMARC Group預測,到2034年,市場規模將達到27億美元,2026年至2034年的複合年成長率為2.65%。醫院、診所和門診手術中心數量的增加是推動市場成長的主要因素。
腹腔鏡手術越來越受歡迎
腹腔鏡疝氣修補術通常使用攝影機和微小切口植入網片。與傳統開放性手術相比,這種方法可以縮短恢復時間、減輕術後疼痛並縮短住院時間。 2024年4月,醫療科技公司TELA Bio宣佈在美國推出OviTex,這是一種用於腹股溝疝氣修補術(IHR)的加強組織基質,專為腹腔鏡和機器人輔助手術設計。該產品為外科醫生提供了柔軟性,可以根據患者需求選擇合適的手術方法。
機器人輔助手術的廣泛應用
對提高網片植入精度、進行更複雜的手術以及最大限度降低併發症風險的需求不斷成長,正在推動市場成長。機器人輔助手術還能為患者帶來許多好處,例如減少出血量、縮小切口以及縮短恢復時間。 2024年5月,Medtronic啟動了更多臨床試驗,旨在將其Hugo機器人輔助手術系統的適應症擴展至疝氣和婦科領域。這進一步提振了疝氣修補網片設備市場的前景。
人們越來越關注個人化患者解決方案
影像技術和電腦建模的許多進步使得術前精準規劃和患者個體化網片設計成為可能,從而推動了市場成長。個人化解決方案旨在最大限度地減少併發症,提高疝氣修補術的成功率,並提升患者的整體滿意度。 2024年1月,Absolutions公司憑藉其腹壁閉合裝置獲得FDA突破性認定,該裝置透過將縫線張力分散到大面積組織上,從而降低疝氣風險。
The global hernia mesh devices market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.65% during 2026-2034. The increasing number of hospitals, clinics, and ambulatory surgical centers is stimulating the market.
Rising Preference for Laparoscopic Procedures
Laparoscopic hernia repair usually involves the use of a camera and small incisions to guide the placement of the mesh. This, in turn, results in quicker recovery times, less postoperative pain, and reduced hospital stays compared to traditional open surgery. In April 2024, one of the medical technology companies, TELA Bio, announced the commercial launch of OviTex inguinal hernia repair (IHR) reinforced tissue matrix, a product tailored for laparoscopic and robotic-assisted procedures, in the U.S. It offers flexibility for surgeons based on patient needs and procedural preferences.
Expanding Adoption of Robotic-Assisted Surgery
The inflating need for improving the accuracy of mesh placement, more complex maneuvers, and minimizing the risk of complications is catalyzing the market. Robotic-assisted surgery also offers benefits, such as reduced blood loss, smaller incisions, and quicker recovery times, for patients. In May 2024, Medtronic initiated additional clinical studies of its Hugo robotic-assisted surgery system to expand its indications to hernia and gynecology. This is bolstering the hernia mesh devices market outlook report.
Increasing Focus on Patient-Specific Solutions
Numerous advancements in imaging technologies and computer modeling, which enable precise preoperative planning and customized mesh designs, are catalyzing the market. Patient-specific solutions aim to minimize complications, enhance the success rates of hernia repairs, and improve overall patient satisfaction. In January 2024, Absolutions received an FDA breakthrough designation for an abdominal wall closure device to reduce the risk of hernia by distributing suture tension over a large area of tissue.
Inguinal hernia dominates the hernia mesh devices market outlook
An inguinal hernia occurs when a portion of the intestine protrudes through a weakened spot in the abdominal muscles. Addressing this common condition, several companies have recently launched innovative products. For example, Medtronic introduced the Parietex Hybrid Mesh, which combines non-absorbable and absorbable components to enhance biocompatibility and tissue integration.
Synthetic mesh currently holds most of the total hernia mesh devices market share
Synthetic mesh devices represent medical implants made from materials like polypropylene, designed to provide support to weakened or damaged tissue. Bard unveiled the Ventralight ST Mesh, featuring a lightweight, large-pore design with a bioresorbable coating that promotes better tissue integration.
Hospitals hold the majority of the global hernia mesh devices market demand
Hernia mesh devices are medical implants used in hospitals to repair hernias by providing additional support to weakened or damaged tissue. Becton, Dickinson, and Company developed an optilene mesh that is engineered to reduce the risk of adhesion and infection while providing robust support for tissue regeneration.
North America exhibits a clear dominance in the market
The hernia mesh devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the hernia mesh devices market analysis report, North America exhibits a clear dominance in the market, driven by advancements in surgical techniques, growing incidences of hernias, and a strong focus on improving patient outcomes. In January 2024, TELA Bio Inc., a commercial-stage medical technology company, introduced LIQUIFIX precision and LIQUIFIX FIX8 laparoscopic open hernia mesh fixation devices in the U.S. Both devices are the only FDA-approved devices that affix mesh and approximate peritoneal tissue with liquid anchors.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: